SCHEMBL23271972

SCHEMBL23271972

CC1=C(C)C(=O)c2c(O)c(O)cc(O)c2C1=O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.59
MEN1 O00255 6/20 0.59
KMT2A Q03164 6/20 0.59
KDM4E B2RXH2 6/20 0.59
USP2 O75604 3/20 0.59
ALDH1A1 P00352 5/20 0.59
RECQL P46063 4/20 0.59
MAPK1 P28482 4/20 0.59
HPGD P15428 3/20 0.59
CYP3A4 P08684 3/20 0.59
ALOX15 P16050 3/20 0.59
MAOA P21397 3/20 0.59
HSD17B10 Q99714 3/20 0.59
TDP1 Q9NUW8 3/20 0.59
BRCA1 P38398 2/20 0.59
CYP1A1 P04798 2/20 0.59
MAOB P27338 2/20 0.59
CYP1B1 Q16678 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59
TTR P02766 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30003480 1.00 MAPT (0.59) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL30002528 0.90 MAPT (0.60) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL5821552 0.90 MAPT (0.60) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL23271652 0.90 MAPT (0.60) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL29470935 0.85 MAPT (0.68) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL6905908 0.85 MAPT (0.68) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL6905151 0.85 MAPT (0.68) MAPTMEN1KMT2AKDM4EUSP2
SCHEMBL27817601 0.84 MAPT (0.83) MAPTMEN1KMT2AKDM4EUSP2
Spinochrome D SCHEMBL30431479 0.81 KDM4E (0.65) MAPTMEN1KMT2AKDM4EUSP2
Spinochrome D SCHEMBL17603111 0.81 KDM4E (0.65) MAPTMEN1KMT2AKDM4EUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11613509-B2 Radical polymerization control agent and radical polymerization control method KAWASAKI KASEI CHEMICALS LTD. (JP) 2023-03-28 US disclosed
CN-110891980-B Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2022-09-30 CN disclosed
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD KAWASAKI KASEI CHEMICALS LTD. (JP) 2021-04-29 US disclosed
CN-110891980-A Radical polymerization control agent and radical polymerization control method 川崎化成工业株式会社 2020-03-17 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11613509-B2 Radical polymerization control agent and radical polymerization control method PPOX, NOX4, CROCC MAPT 188/4885MEN1 2943/4885KMT2A 2246/4885
US-20210122692-A1 RADICAL POLYMERIZATION CONTROL AGENT AND RADICAL POLYMERIZATION CONTROL METHOD PPOX, NOX4, CROCC MAPT 188/4885MEN1 2943/4885KMT2A 2246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.